A CGRP receptor antagonist peptide formulated for nasal administration to treat migraine.
von Mentzer B, Russo AF, Zhang Z, Kuburas A, Killoran PM, D'Aloisio V, Nizic L, Capel V, Kendall DA, Coxon CR, Hutcheon GA.
von Mentzer B, et al. Among authors: killoran pm.
J Pharm Pharmacol. 2020 Oct;72(10):1352-1360. doi: 10.1111/jphp.13317. Epub 2020 Jun 25.
J Pharm Pharmacol. 2020.
PMID: 32588458
Free PMC article.